Battery materials company Talga Group Ltd (ASX:TLG) has opened its new Battery Centre of Excellence in Cambridge, UK.
The centre is a significant expansion of Talga’s UK R&D facilities, first launched in 2016.
Focusing on battery material innovations, development and characterisation, the centre is designed to complement Talga’s existing facilities in Sweden (Talnode-C EV qualification production and battery quality control labs) and Germany (processing technology scale-up and graphene production).
The centre increases Talga’s capacity to develop its Talnode battery materials, including next generation silicon and solid state anodes, and performance-boosting conductive additives for cathodes. This development work aims to diversify Talga’s product portfolio into emerging energy storage materials and future scope technologies. In addition, the centre is home to Talga’s material recycling and repurposing R&D operations.
While Talga scales up its world-class battery anode products on a commercial scale, we look to accelerate our next generation battery technology materials,” Managing Director, Mark Thompson, said.
“Our new UK Centre of Excellence provides a strategic edge in material innovation for future growth, while complementing our other European facilities and increasing operational efficiency. The Cambridge location provides access to the latest thinking and cutting-edge technology to develop the battery materials of the future.”
The Centre of Excellence forms a key part of Talga’s strategy to become a global player in the battery supply chain, and its mission to enable the world’s most sustainable batteries and consumer products.
The centre presently employs ten staff, including electrochemists, chemical engineers and materials scientists, with room to expand. Talga’s presence in Cambridge also provides access to the varied innovation grant programmes sponsored by the UK Government.
As Europe’s largest technology cluster, Cambridge hosts a diverse and cutting-edge innovation culture which has attracted elite researchers and industry-leading companies such as Amazon, Apple and AstraZeneca.
